J Biol Chem, Vol. 274, Issue 31, 22025-22032, July 30, 1999
Nuclear Import of Plasmid DNA in Digitonin-permeabilized Cells
Requires Both Cytoplasmic Factors and Specific DNA Sequences*
G. Lee
Wilson
,
Brenda S.
Dean
,
Gan
Wang§¶, and
David
A.
Dean
¶
From the Departments of
Microbiology and Immunology
and § Structural and Cellular Biology and the
¶ University of South Alabama Comprehensive Sickle Cell Center,
College of Medicine, University of South Alabama,
Mobile, Alabama 36688
 |
ABSTRACT |
Although much is known about the mechanisms of
signal-mediated protein and RNA nuclear import and export, little is
understood concerning the nuclear import of plasmid DNA. Plasmids
between 4.2 and 14.4 kilobases were specifically labeled using a
fluorescein-conjugated peptide nucleic acid clamp. The resulting
substrates were capable of gene expression and nuclear localization in
microinjected cells in the absence of cell division. To elucidate the
requirements for plasmid nuclear import, a digitonin-permeabilized cell
system was adapted to follow the nuclear localization of plasmids.
Nuclear import of labeled plasmid was time- and
energy-dependent, was inhibited by the lectin wheat germ
agglutinin, and showed an absolute requirement for cytoplasmic extract.
Addition of nuclear extract alone did not support plasmid nuclear
import but in combination with cytoplasm stimulated plasmid nuclear
localization. Whereas addition of purified importin
, importin
,
and RAN was sufficient to support protein nuclear import, plasmid
nuclear import also required the addition of nuclear extract. Finally,
nuclear import of plasmid DNA was sequence-specific, requiring a region
of the SV40 early promoter and enhancer. Taken together, these results confirm and extend our findings in microinjected cells and support a
protein-mediated mechanism for plasmid nuclear import.
 |
INTRODUCTION |
The nuclear envelope presents an effective barrier between the
nuclear and cytoplasmic compartments of the cell. Although it is
impermeant to large non-nuclear molecules, a multitude of macromolecules must enter and exit the nucleus across this envelope every second in order for the cell to live. All macromolecular exchange
between the nucleus and the cytoplasm studied to date occurs through
the nuclear pore complex
(NPC),1 is
signal-dependent, and utilizes a series of receptor
proteins (for a review see Ref. 1). In the case of proteins destined for the nucleus, the nuclear localization signal (NLS) interacts with
one of a growing number of importin family members to target the
complex to the NPC. In the classical case of NLS-containing proteins,
the protein binds to importin
, the NLS "receptor," which in
turn interacts with importin
. Once at the NPC, the complex
interacts with the small GTP-binding protein RAN in its GDP-bound state
and its accessory factor NTF2 while being translocated across the NPC.
After translocation into the nucleus, the complex disassembles because
of the conversion of RAN-GDP to RAN-GTP by exchange or replacement and
the importins return to the cytoplasm (2). Similar scenarios of
receptor proteins interacting with signals to mediate translocation
across the nuclear envelope also occur for the nuclear export of
proteins (e.g. exportin and the nuclear export signal) and
viral mRNAs (Crm1p, HIV Rev, and the Rev response element), and the
nuclear import of small nuclear RNAs that contain both protein-encoded
NLSs and the trimethylguanosine cap as import signals (1, 3).
We have recently shown that the nuclear import of plasmid DNA (pDNA)
also uses a signal-mediated pathway to enter the nucleus. Using a
microinjection approach, we demonstrated that pDNA can enter the
nucleus in the absence of cell division by a process that is consistent
with transport through the NPC (4). Such nuclear import has been
detected in all mammalian cells tested to date, including those of
mouse, rat, monkey, human, and chicken, as well as those from all cell
types, including smooth and striated muscle, fibroblasts, endothelial
cells, and epithelial cells. Furthermore, this import is
sequence-specific: plasmids containing as little as 80 bp of the SV40
enhancer/early promoter region are targeted to the nucleus in the
absence of cell division, whereas plasmids lacking this sequence remain
cytoplasmic (4).2 This
sequence specificity appears unique to SV40, because several other
strong viral promoter and enhancer sequences, including the immediate
early promoter/enhancer of cytomegalovirus and the long terminal repeat
of Rous sarcoma virus, fail to promote nuclear import.2
Based on the sequences required for plasmid nuclear import, we have
proposed a working model in which pDNA import is mediated by newly
synthesized transcription factors and other sequence-specific DNA-binding proteins that bind to the DNA in the cytoplasm, thus attaching NLSs to the DNA for recognition and transport by the NLS-dependent machinery. In order to further study the
mechanisms of pDNA nuclear import, an in vitro system was
required. To this end, we have developed an approach to label plasmid
DNA that maintains its biological activity and have adapted the
digitonin-permeabilized cell assay to study plasmid nuclear localization.
 |
EXPERIMENTAL PROCEDURES |
Plasmids--
The 4.2-kb plasmid pUSAG3 contains a 60-bp
sequence from the human G gamma globin promoter (
315 to
255)
inserted into the SmaI site of the GFP promoter reporter
vector pEGFP-1 (CLONTECH Laboratories, Palo Alto,
CA) in the same orientation as the GFP gene (see Fig. 1). To create
pUSAG3
SV40 that lacks the SV40 nuclear targeting sequence, a 913-bp
fragment containing the SV40 origin and early promoter/enhancer region
was removed from pUSAG3 by digestion with StuI and
SspI and religation. pUSAG9 is a 14.4-kb plasmid containing
the human globin locus control region and the A-
globin and
globin genes (nucleotides 38084-43975 and 60409-65475, EMBL ID:
HSHBB4R1) inserted into the SmaI site of pEGFP-1. pUSAG9 also contains the 60-bp PNA-binding site found in pUSAG3.
Rhodamine-labeled pGenegrip blank vector and Rhodamine-labeled
pGenegrip GFP vector were obtained from Gene Therapy Systems (San
Diego, CA).
PNA Binding--
A fluorescein-labeled PNA clamp
(NH2-fluorescein-OTTTTCTTCTCOOOJTJTTJTTTT-COOH; Fl-PNA) was
synthesized by Perseptive Biosystems (Framingham, MA) to bind to the
target GAGAAGAAA present in the 60-bp G
globin promoter fragment
(see Fig. 1). Fl-PNA (3 µM) was reacted with the purified
plasmids at a 10:1 molar ratio in TE buffer (10 mM Tris, pH
8, 1 mM EDTA) for 3 h at 37 °C. The reactions were
diluted into 2 ml of TE buffer and concentrated to 50 µl in a
Centricon-30 microconcentration device, diluted again to 2 ml, and
reconcentrated to a final concentration of between 0.1 and 0.2 mg/ml
plasmid. Approximately 30 µg of pDNA was labeled in a typical
experiment. Labeled DNAs were stored at
80 °C. The pGenegrip
vectors were obtained as labeled DNAs from the manufacturer.
Cells and Microinjection--
HeLa cells were grown on
coverslips in minimum essential medium (Life Technologies, Inc.)
containing 10% fetal bovine serum and antibiotics in a humidified
incubator at 37 °C with 5% CO2. Purified PNA-labeled
pDNA was suspended in phosphate-buffered saline at a concentration of
0.1 mg/ml and microinjected into the cytoplasm of cells grown on etched
coverslips as described (4). With a microinjection volume of
approximately 3 × 10
10 ml/cell,2 about
2,000 plasmids were delivered per cell. The cells were incubated for
various times, rinsed in phosphate-buffered saline, fixed for 15 min at
4 °C in 3% paraformaldehyde in phosphate-buffered saline, and
mounted with
4,6-diamidino-2-phenylindole/diazobicyclo[2.2.2]octane.
Expression and Purification of His-tagged Importin
, Importin
, and RAN--
The human genes for importin
and RAN were
polymerase chain reaction-amplified from reverse-transcribed HeLa cell
RNA using oligonucleotide primers containing unique restrictions sites
at the ends and cloned into the corresponding restriction sites of ptrcHisB (Invitrogen, San Diego, CA). A plasmid expressing the yeast
importin
homologue, hSRP1
, was obtained from K. Weis (EMBL,
Heidelberg, Germany) (5). The plasmids were transformed into
Escherichia coli BL21(DE3) and expressed and purified by nickel affinity chromatography as described for the appropriate protein
(5, 6).
Permeabilized Cell Assays--
Permeabilized cell assays were
performed as described previously using HeLa cells grown on glass
coverslips (7). Briefly, cells were grown to 60% confluency, washed
with wash buffer (20 mM HEPES, pH 7.3, 110 mM
potassium acetate, 5 mM sodium acetate, 2 mM
MgCl2, 1 mM EGTA, 2 mM
dithiothreitol), and permeabilized with 40 µg/ml digitonin in wash
buffer for 6-8 min on ice. The cells were rinsed for 5-10 min with
several changes of cold wash buffer, and the excess buffer was removed
before the assays were initiated. Reactions were carried out in a
transport buffer consisting of wash buffer containing 1 mg/ml bovine
serum albumin, 1 µg/ml aprotinin, leupeptin, and pepstatin, 1 mM GTP, 2 mM ATP, 10 mM phosphocreatine, and 20 units/ml of creatine phosphokinase. Rhodamine- or fluorescein-labeled NLS peptide-conjugated BSA (Fl- or Rh-BSA-NLS) were included at 25 µg/ml and fluorescein-labeled PNA plasmids were
present at 10 µg/ml. Where indicated, cytoplasmic extracts prepared
from HeLa cells (7) were added to between 5 and 7 mg/ml, HeLa cell
nuclear extracts (in vitro transcription grade, Promega,
Madison, WI) were added to 0.25 mg/ml, and affinity purified, recombinant his-tagged RAN, importin
, and importin
were used at
0.5 mg/ml each. The lectins wheat germ agglutinin (WGA) and concanavalin A were added to 0.1 mg/ml each. In reactions lacking ATP
and GTP, nucleotide triphosphates, phosphocreatine, and
creatine-phosphokinase were omitted from the transport buffer and
ATP-depleted extracts were prepared by incubating the extracts with 10 units/ml apyrase for 30 min before addition to the cells. Other
competitors were added as indicated in the text. The cells were
incubated in a humidified chamber at 37 °C for 4 h, unless
otherwise indicated. The reactions were terminated by washing the cells
in wash buffer and fixing them at 4 °C for 15 min in 3%
paraformaldehyde in wash buffer. The cells were mounted with
4,6-diamidino-2-phenylindole/diazobicyclo[2.2.2]octane, and 0.5-µm
sections were viewed by confocal microscopy using an ACAS 570 laser-scanning confocal microscope.
Southern Blot--
PNA-labeled and unlabeled plasmids were
incubated in transport buffer containing HeLa cytoplasmic and nuclear
extracts (5 and 0.25 mg/ml, respectively) for 4 h at 37 °C. At
the end of the reaction, the DNA was extracted with phenol:chloroform
and chloroform alone. 10 µg of tRNA were added, and the DNA was
precipitated with ethanol overnight at
20 °C. The DNA was
resuspended in 10 µl of TE buffer and separated on a 1% agarose gel,
transferred to nylon, and immobilized by UV irradiation as described
(8). The Blot was prehybridized at 42 °C for 4 h in 50%
formamide containing 5× SSC, 5× Denhardt's solution, and 2 mg/ml
sheared salmon sperm DNA and hybridized with 1 × 106
cpm/ml of nick translated pUSAG3 and 1 × 106 cpm/ml
of nick translated pGenegrip Blank for 18 h at 37 °C. The blot
was washed at room temperature for 15 min each in 2× SSC/0.1% SDS,
0.5× SSC/0.1% SDS, 0.5× SSC/0.1% SDS, and for 30 min at 37 °C in
0.1× SSC/1% SDS, dried, and exposed to film.
 |
RESULTS |
Fluorescent PNA-labeled Plasmid DNA Is Transported into the Nuclei
of Cytoplasmically Microinjected Cells--
Although we have begun to
make progress elucidating the mechanisms of nuclear import of plasmid
DNA using microinjection and in situ hybridization, this
method has its limitations because of the fact that it detects DNA in
fixed samples only. A better substrate with which to follow the
transport reactions in real time would be fluorescently labeled pDNA.
In order to produce such substrate, we tried a variety of labeling
techniques including incorporation of fluorescent nucleotide analogues
(e.g. fluorescein-dUTP) by polymerase chain reaction or nick
translation followed by ligation to form intact plasmid, covalent and
noncovalent high affinity intercalating dyes (e.g. ethidium
bromide monoazide and TOTO-1), and reaction of supercoiled plasmid with
photoactivatable fluorophore conjugates. Although all of the methods
produced fluorescently labeled DNA, two problems limited the use of
these labeled DNAs as substrates for import reactions. First, several
of the techniques produced either linear DNA or low yields of
circularized plasmid, making their use impractical. More importantly,
all of the labeled DNAs became inactive in both transcription of
reporter genes or migration of the DNA to the nucleus in microinjected
cells (not shown). We were successful, however, when we used a
fluorescently labeled peptide nucleic acid (Fl-PNA) clamp; the
resulting plasmids were transcriptionally active and able to localize
to the nucleus as did unlabeled native
plasmid.3
The PNA we used to label plasmids bound to a 10-nucleotide sequence
(GAGAAGAAAA) within the G
globin promoter. The target site was
cloned upstream of the GFP gene, well removed from the SV40 nuclear
targeting sequence, which was downstream of the GFP gene, 1.6 kb away
(Fig. 1). One half of the PNA invaded the
target site and hybridized to its complementary sequence through
standard Watson-Crick base pairs, and the other half of the PNA folded back onto the PNA:DNA double helix to form a triplex structure using
Hoogstein base pairs (9). Fluorescein was bound to the amino terminus
of the PNA and did not interfere with binding of the PNA to the target.
The resulting triplex structure is highly stable (10), and because the
backbone of the PNA utilizes peptide bonds, it is resistant to nuclease
digestion and even incubation in serum (11). In our hands, the PNA
could not be dissociated from the bound state when incubated with a
1000-fold molar excess of target sequence at 37 °C for 8 h as
followed by gel shift assays (not shown).
When microinjected into the cytoplasm of TC7 cells, native pDNA
localizes to the nucleus within 6-8 h as detected by in
situ hybridization (4). When Fl-PNA-labeled pUSAG3 was similarly microinjected into the cytoplasm, it localized to the nucleus within
6 h (Fig. 2). Further, the
subnuclear distribution of the labeled pDNA and its absence in the
nucleoli was very similar to that seen with native pDNA and in
situ hybridization (4). Thus, because the Fl-PNA/pDNA maintained
the same biological properties as unmodified plasmid, we used it as a
substrate in permeabilized cell assays to dissect the transport
mechanism.

View larger version (191K):
[in this window]
[in a new window]
|
Fig. 2.
Nuclear localization of Fl-PNA/pDNA in
microinjected cells. TC7 cells were cytoplasmically microinjected
with approximately 1000 copies/cell of F1-PNA-conjugated pUSAG3 (0.1 mg/ml). 6 h later, the cells were fixed in 4% paraformaldehyde and
viewed by confocal microscopy. Bar = 10 µm.
|
|
Reconstitution of Plasmid DNA Nuclear Import in Permeabilized
Cells--
Digitonin-permeabilized HeLa cells have been used
effectively to reconstitute nuclear import and export reactions of
proteins, small nuclear RNA, and small linear DNA (7, 12-15). We also have used this system to study the requirements for fluorescently labeled pDNA nuclear entry. HeLa cells were permeabilized with digitonin and washed to remove cytoplasmic components as described previously (7). Because all signal-mediated nuclear import reported to
date has been shown to require cytosolic proteins (e.g.
importins, exportins, etc.), we reasoned that signal-mediated pDNA
nuclear import would behave similarly. Thus, we added cytoplasmic extracts prepared from HeLa cells along with an ATP-regenerating system, protease inhibitors, buffer, salts, and GTP to the assays. As a
positive control for nuclear import, we also followed the nuclear
accumulation of rhodamine-labeled BSA conjugated to a synthetic NLS
peptide (Rh-BSA-NLS) to ensure that all the components were active (not
shown). As seen in Fig. 3, significant
Fl-PNA/pDNA import is observed within 90 min and is maximal by 4 h. In contrast, Rh-BSA-NLS was maximally imported into the nuclei by 30 min (not shown). That the extract was still fully functional and that
the nuclei were not leaky at these late times were confirmed by
demonstrating that protein nuclear import occurred in an
NLS-dependent manner when the substrate was added 4-8 h
after the cells had been permeabilized and reacted with cytoplasmic
extracts (not shown). Thus, neither the cells nor the extracts lost
functional activity or selectivity over this time course. Because
maximal nuclear localization was observed by 4 h, this time point
was used in the remainder of the experiments.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 3.
Time course of Fl-PNA/pDNA nuclear
localization in permeabilized cells. HeLa cells were permeabilized
with digitonin and washed in import buffer as described under
"Experimental Procedures." The reactions were carried out at
37 °C in transport buffer containing an ATP-regenerating system, 2 mM GTP, 5-7 mg/ml HeLa cytoplasmic extract, and 10 µg/ml
Fl-PNA/pUSAG3. Reactions were stopped at 0.5 h (A),
1 h (B, 1.5 h (C), 2 h
(D), 3 h (E), and 4 h (F) by
washing the cells with wash buffer and fixing them at 4 °C for 15 min in 3% paraformaldehyde in wash buffer. Half-micron sections of the
cells were observed and digitized by confocal microscopy.
|
|
To determine whether cytoplasmic extracts were indeed required for the
nuclear import of pDNA, reactions were performed with various
combinations of cellular extracts (Fig.
4). Our working model for signal-mediated
pDNA nuclear import postulates that sequence specificity is mediated by
transcription factors and DNA-binding proteins. These proteins bind to
sites within the SV40 DNA nuclear targeting sequence while the DNA and
the proteins are in the cytoplasm, and the NLSs present on the
transcription factors enable the pDNA-protein complex to utilize the
NLS-dependent machinery for nuclear import. This model
predicts that cytoplasmic extracts containing both DNA-binding proteins
and the NLS-dependent import machinery are necessary for
nuclear import of pDNA. In support of this model, no nuclear import was
observed in the absence of cytoplasmic extract of either a 4.2-kb
plasmid, pUSAG3, or a 14.4-kb plasmid, pUSAG9, both of which contain
the PNA-binding site and the SV40 DNA nuclear targeting sequence (Fig.
4, A and E). In contrast, when cytoplasmic
extract was provided, significant nuclear import of both plasmids was
detected at 4 h (Fig. 4, C and G).
Interestingly, many nuclei showed distinct rim staining of the larger
plasmid (Fig. 4G). This suggests either that import was not
complete at 4 h and larger plasmids take longer to enter the
nucleus or that one or more factors are limiting for efficient nuclear
import of the larger plasmid. Because our model predicts that
transcription factors and other DNA-binding proteins mediate nuclear
pDNA import, nuclear extracts were tested for their ability to support
or enhance nuclear import of the plasmids. Although the addition of
nuclear extract alone did not support nuclear localization of the
14.4-kb plasmid (Fig. 4F), it did allow a low level of
import of the smaller plasmid (Fig. 4B). Because all
components of the NLS-dependent import machinery can be
found in the nucleus at levels much less than those in the cytoplasm, this is not a completely surprising result. When both nuclear and
cytoplasmic extracts were provided to the cells, import of both
plasmids was more robust (Fig. 4, D and H).
Further, no rim staining was observed for either of the plasmids.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 4.
Requirement of cellular extracts for nuclear
import of pDNA. Digitonin permeabilized HeLa cells were incubated
for 4 h at 37 °C with either the Fl-PNA conjugated 4.2-kb
plasmid pUSAG3 (A-D) or the Fl-PNA conjugated 14.4-kb
plasmid pUSAG9 (E-H), both at 10 µg/ml, in the presence
or absence of cellular extracts. BSA was added to 10 mg/ml to cells
incubated in the absence of extracts (A and E).
HeLa cell nuclear extract (Promega) was added to 0.5 mg/ml
(B and F). HeLa cell cytoplasmic extract was
added to 5 mg/ml in the absence (C and G) or
presence (D and H) of nuclear extract.
|
|
Nuclear Import of pDNA Requires Energy and Is Blocked by
WGA--
Signal-mediated nuclear import and export of proteins and
RNAs has been shown to be energy-dependent (7, 12, 14, 15). Previous experiments from our laboratory using a microinjection approach have demonstrated that this is also the case for plasmid nuclear import (4). This energy dependence was confirmed in the
permeabilized cell system (Fig. 5). When
GTP and the ATP-regenerating system were omitted from the assays and
endogenous stores of nucleotide triphosphates were depleted from the
cytoplasmic and nuclear extracts by pretreatment with apyrase, no
nuclear localization of pDNA was detected with any combination of
extracts (Fig. 5). Similarly, these treatments also prevented nuclear
accumulation of Rh-BSA-NLS (data not shown), confirming that ATP levels
were sufficiently low to block NLS-mediated nuclear import.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 5.
Energy dependence of pDNA nuclear
import. Digitonin permeabilized HeLa cells were incubated for
4 h at 37 °C with transport buffer lacking ATP,
phosphocreatine, creatine phosphokinase, GTP, and Fl-PNA/pUSAG3 (10 µg/ml). The cells were then washed, fixed with 3% paraformaldehyde,
and viewed by confocal microscopy. Cells incubated in the absence of
cellular extracts contained 10 mg/ml BSA (A). Nuclear
(B and D) and cytoplasmic (C and
D) extracts were depleted of endogenous nucleotide
triphosphates by preincubating the extracts with 10 units/ml apyrase at
25 °C for 30 min.
|
|
Addition of the lectin WGA that binds to N-acetylglucosamine
residues present on a class of NPC proteins also inhibited nuclear accumulation of pDNA in permeabilized cells (Fig.
6). When added to cells, WGA completely
inhibited the nuclear import of Fl-PNA/pUSAG3 (Fig. 6C)
compared with the control reaction lacking added lectin (Fig.
6A), whereas addition of the lectin concanavalin A that has
been shown not to alter transport through the NPC had no effect on pDNA
import (Fig. 6B).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of lectins on pDNA nuclear
import. Permeabilized HeLa cells were incubated with transport
buffer containing Fl-PNA/pUSAG3 (10 µg/ml) for 4 h at 37 °C.
All reactions contained HeLa cytoplasm at 5 mg/ml and either no
additional lectin (A), concanavalin A (0.1 mg/ml;
B) or wheat germ agglutinin (0.1 mg/ml; C).
|
|
Nuclear Import of pDNA Requires the NLS Import Machinery as Well as
Additional Factors--
Based on the above experiments, it appeared
that the need for cytoplasmic extracts for pDNA nuclear import was to
supply components of the NLS-dependent transport machinery.
Thus, we expressed and affinity purified histidine-tagged fusion
proteins corresponding to importin
, importin
, and RAN. The
proteins were judged to be >95% pure based on Coomassie Blue-stained
polyacrylamide gels (data not shown). These were then added with either
Rh-BSA-NLS or Fl-PNA/pUSAG3 to permeabilized cells, in the presence or
absence of nuclear extract prepared from HeLa cells to provide the
appropriate NLS-containing DNA-binding proteins (Fig.
7). As seen previously, in the absence of
cytoplasmic extract or the importins and RAN, no nuclear import of
either pDNA or Rh-BSA-NLS was observed (Fig. 7, A and
E). Similarly, little or no nuclear import of either substrate was seen in the presence of nuclear extract alone (Fig. 7,
B and F). Although the addition of importin
,
importin
, and RAN was sufficient to drive the nuclear localization
of the NLS-containing reporter protein (Fig. 7G), they were
not sufficient to support import of pDNA (Fig. 7C). This
suggested either that plasmid DNA does not use the importin
/
pathway for its nuclear import or that additional factors are required
to allow the importins to bind to the DNA. Because neither importin
nor
bind to DNA, for them to mediate nuclear import of pDNA, an
intermediary "adapter" protein would be required that binds to DNA
and contains an NLS for recognition by the importins. Thus, when a
nuclear extract was provided in addition to the importins and RAN,
significant nuclear localization of Fl-PNA/pUSAG3 was observed (Fig.
7D). The presence of the nuclear extract had little effect
on the import of Rh-BSA-NLS (Fig. 7H).

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 7.
Reconstitution of pDNA nuclear import using
purified importins and RAN. HeLa cells were permeabilized and
incubated with transport buffer containing Fl-PNA/pUSAG3 (10 µg/ml;
A-D) or Rh-BSA-NLS (25 µg/ml; E-H) at
37 °C with the indicated additions. Rh-BSA-NLS import reactions were
incubated for 30 min, and pDNA import reactions proceeded for 4 h.
His-tagged importin , importin , and RAN were purified by nickel
affinity chromatography and concentrated for addition to the reactions.
The reactions contained BSA alone (10 mg/ml; A and
E), nuclear extract alone (0.5 mg/ml; B and
F), importin , importin , and RAN (0.5 mg/ml each;
C and G), or importin , importin , RAN, and
nuclear extract (D and H).
|
|
To ensure that all three components of the nuclear import machinery
(i.e. importin
, importin
, and RAN) were indeed
required for pDNA nuclear entry, import reactions were performed in
which each of the factors was left out separately (Fig.
8). As was seen in Fig. 7, significant
nuclear import of both pDNA and Rh-BSA-NLS was observed in the presence
of all three components and nuclear extract (Fig. 8, A and
E). However, when the import reactions were performed with
nuclear extract and importin
and RAN (Fig. 8, B and
F), importin
and RAN (Fig. 8, C and
G), or importin
and importin
(Fig. 8, D
and H), nuclear import of both substrates was eliminated.
The nuclear rim staining of Rh-BSA-NLS observed in the presence of the
importins alone (Fig. 8H) was expected based on previous
reports (16) and confirms the fidelity of the recombinant proteins and
the experimental system. Thus, similar to "classical" protein
nuclear import, both the importins and RAN are required for plasmid
nuclear entry.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 8.
Requirement of importin
, importin , and RAN for
nuclear import. HeLa cells were permeabilized and incubated with
transport buffer containing Fl-PNA/pUSAG3 (10 µg/ml; A-D)
or Rh-BSA-NLS (25 µg/ml; E-H) at 37 °C with the indicated
additions. Rh-BSA-NLS import reactions were incubated for 30 min, and
pDNA import reactions proceeded for 4 h. All reactions contained
HeLa cell nuclear extract (0.5 mg/ml). Affinity purified His-tagged
importins and RAN were added to 0.5 mg/ml each. The reactions contained
importin , importin , and RAN (A and E),
importin , and RAN (B and F), importin ,
and RAN (C and G) or importin and importin
(D and H).
|
|
Sequence Specificity of pDNA Nuclear Import--
Competition
experiments suggested that the nuclear import of Fl-PNA/pDNA was
signal-mediated. When permeabilized cells were incubated with
Fl-PNA/pUSAG3 in the presence of ATP and cytoplasmic and nuclear
extracts, the plasmid localized to the nuclei of cells (Fig.
9A). Addition of a 1000-fold
molar excess of BSA-NLS had no effect on the nuclear localization of
the plasmid (Fig. 9B). This is not entirely surprising,
because the small NLS-containing protein is imported into the nuclei
within minutes of addition and thus is not a true competitor for the
NLS-dependent machinery, which can recycle back to the
cytoplasm for import of pDNA. Striking inhibition of pDNA nuclear
import was seen when a 100-fold molar excess of SV40 DNA was added to
the reaction (Fig. 9D), whereas a similar excess of pUC19
had no effect on pDNA import (Fig. 9C). Because both pUSAG3
and SV40 DNA share the 360-bp SV40 promoter/enhancer region that is
necessary in intact cells for nuclear targeting of pDNA, it appeared
likely that the permeabilized cell system faithfully reproduced this
sequence specificity. To test this directly, a 913-bp fragment
containing the 360-bp SV40 DNA nuclear targeting sequence was removed
from pUSAG3 to create pUSAG3
SV40. This plasmid was labeled with
Fl-PNA and used in the permeabilized cell assay in parallel to the
parent Fl-PNA/pUSAG3 (Fig. 10). As expected, neither plasmid was able to localize to the nucleus in the
absence of cytoplasmic extract (Fig. 10, A and
C). The plasmid lacking the SV40 sequence was also unable to
localize to the nuclei in the presence of cytoplasmic extract, although
faint rim staining was detected (Fig. 10D), whereas the
parent pUSAG3 was imported efficiently (Fig. 10B). These
experiments confirm that pDNA nuclear import in permeabilized cells
faithfully represents that seen in intact cells and that nuclear uptake
of plasmid DNA is sequence-specific.

View larger version (149K):
[in this window]
[in a new window]
|
Fig. 9.
Competition of Fl-PNA/pDNA nuclear import by
plasmid DNA and BSA-NLS. Permeabilized HeLa cells were incubated
for 4 h at 37 °C with transport buffer containing HeLa
cytoplasmic extract (5 mg/ml) and Fl-PNA/pUSAG3 (10 µg/ml) in the
absence (A) or presence of a 1000-fold molar excess of
BSA-NLS (0.23 mg/ml; B), a 100-fold excess of pUC19 (0.7 mg/ml; C), or a 100-fold molar excess of SV40 DNA (1.3 mg/ml; D).
|
|

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 10.
Sequence specificity of pDNA nuclear import
in permeabilized cells. Permeabilized HeLa cells were incubated
for 4 h at 37 °C in transport buffer containing BSA alone
(A and C) or HeLa cytoplasmic extract at 5 mg/ml
(B and D). The substrates used were either
Fl-PNA/pUSAG3 (A and B) or Fl-PNA/pUSAG3 SV40
(C and D), both present at 10 µg/ml.
|
|
PNA-labeled and Unlabeled Plasmid DNA Remains Largely Intact in
Cytoplasmic Extract--
If significant degradation of pDNA is
occurring in our system, the apparent nuclear import of Fl-PNA/pDNA
could actually represent nuclear localization of small, labeled DNA
fragments or free Fl-PNA alone liberated from the pDNA substrate upon
degradation. This did not appear to be the case, because if plasmid DNA
was degraded to release smaller fragments or free Fl-PNA,
Fl-PNA/pUSAG3
SV40 should have appeared nuclear in the permeabilized
cell assays as did Fl-PNA/pUSAG3 (Fig. 10). To test this directly, a
Southern blot was performed on both Fl-PNA-labeled and unlabeled pDNA
that had been incubated with or without cytoplasmic extract for 4 h at 37 °C, just as in our permeabilized cell assay (Fig.
11). Both Fl-PNA-labeled and unlabeled
pUSAG3 were used for the Southern blot. A second rhodamine-labeled
PNA-complexed plasmid, pGenegrip-GFP ((17), Gene Therapy Systems, La
Jolla, CA), that expresses GFP but does not contain the SV40 DNA
nuclear targeting sequence was also used in the Southern blot to
determine the fate of plasmids lacking the SV40 sequence. This plasmid,
like pUSAG3
SV40, also failed to be imported into nuclei (not shown).
As can be seen in Fig. 11 (lanes 1-3), both the PNA-labeled
and unlabeled plasmids used as substrate were predominantly
supercoiled, with small amounts of open circular and linear DNA. After
4 h of incubation in cytoplasmic extract, all of the supercoiled
form of these three plasmids had been converted to linear and open
circular DNA, but relatively little of the DNA had been degraded
further (Fig. 11, lanes 4-6). Thus, neither the presence of
the PNA or of the SV40 sequence altered the stability of the plasmids,
and it can be concluded that the observed "import" was indeed that
of pDNA.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 11.
Degradation of pDNA in cytoplasmic
extract. Plasmid DNA (0.1 µg) was incubated for 4 h at
37 °C with HeLa cell cytoplasmic extract (5 mg/ml) in transport
buffer. Protein was removed by phenol:chloroform extraction, and the
DNAs were separated by agarose gel electrophoresis, transferred to a
nylon membrane, and probed using a mixture of 32P-labeled
pUSAG3 and pGenegrip blank. Lanes 1-3 contain 0.1 µg of
unincubated plasmid used as starting material, and lanes
4-6 contain DNA incubated with cytoplasmic extract. Three
plasmids were used: Fl-PNA/pUSAG3 (lanes 1 and
4), rhodamine-labeled PNA/pGenegrip-GFP (lanes 2 and 5), and unlabeled pUSAG3 (lanes 3 and
6).
|
|
 |
DISCUSSION |
Using the digitonin-permeabilized cell assay developed to study
the nuclear import of NLS-containing proteins (7), we have shown that
plasmid DNA can enter the nuclei of cells. The ability to label
supercoiled plasmids at a specific site using a fluorescently labeled
PNA (18) while maintaining their transcriptional (10)3 and
migratory activity has allowed us to follow the nuclear import of
plasmids as opposed to linear DNA fragments. That plasmids labeled in
this manner can be found to enter the nucleus in microinjected cells,
as do unmodified plasmids, confirms that PNA-labeled plasmids are
substrates relevant for studying plasmid nuclear import in vitro. Plasmid nuclear import in digitonin permeabilized cells is
energy-dependent, is inhibited by the NPC-binding lectin
WGA, and requires cytoplasmic extracts. As has been found for the
nuclear localization of NLS-containing proteins (1), the proteins
necessary in the cytoplasmic extracts for plasmid nuclear uptake
include importin
and
, and RAN. However, although addition of
these proteins alone is sufficient to reconstitute BSA-NLS nuclear
import, proteins present in nuclear extract are also required for pDNA nuclear entry. This, coupled with the finding that plasmid nuclear import is sequence-specific in both permeabilized cells and
microinjected cells, supports a model for pDNA nuclear import in which
DNA-binding proteins that contain NLSs act as intermediaries to couple
the NLS import machinery to pDNA.
The development of PNA clamps as a way to specifically label pDNA at
discrete sites has enabled these studies to be performed. Although
multiple fluorescent labeling techniques were tested and found to
produce highly modified DNA, none of them proved useful because they
all destroyed the ability of the DNA to localize to the nucleus in
microinjected cells. Since these techniques targeted nucleotides
randomly throughout the plasmid, it is likely that they labeled sites
within DNA sequences necessary for nuclear import, thus making it
impossible for the appropriate DNA-binding proteins to make contact
with the plasmid and mediate import. The ability to place the PNA
target sequence far away from the DNA nuclear import sequence, and any
desired transgene to be expressed, has allowed us to produce
fluorescent pDNA that is supercoiled and able to target to the nucleus.
The resulting PNA-labeled plasmids target to the nucleus with the same
time course as native plasmid in microinjected cells and, further,
distribute within the nucleus similarly. The exclusion of Fl-PNA/pDNA
from the nucleoli and the somewhat punctate distribution within the
nucleoplasm are reminiscent of the distribution of SV40 DNA in injected
cells (4).
Relatively little degradation of unlabeled and Fl-PNA-labeled plasmid
DNA was observed by Southern blot. Although none of the DNA remained in
the supercoiled state after 4 h in cytoplasmic extract, greater
than 80% of the DNA detected by hybridization was in either the open
circular or linear form. Lack of cytoplasmic plasmid degradation has
also been seen in microinjected cells based on the observation that as
few as 10 copies of a plasmid injected into the cytoplasm can direct
gene expression within 8 h.2 A similar lack of
degradation of DNA by cytoplasmic extracts or in intact cells has also
been seen by others (13, 19, 20). Because plasmids containing or
lacking the SV40 DNA nuclear targeting sequence showed essentially the
same levels of conversion to other forms and because only one of them
displayed nuclear localization, it is unlikely that the nuclear import
observed was due to diffusion or import of PNA alone or small DNA
fragments containing the PNA-binding site bound to PNA. The energy
dependence of nuclear import and inhibition by WGA demonstrate that
Fl-PNA/pDNA nuclear localization is an active transport process.
Although active transport could also account for nuclear import of free
Fl-PNA or small DNA fragments, it is unlikely, because of the findings
that small oligonucleotides appear to enter the nucleus in an
energy-independent manner, consistent with diffusion (13, 21, 22).
Thus, the import we observe is likely that of a mix of supercoiled,
open circular, and full-length linear plasmid DNA.
The observation that proteins present in cytoplasmic extract are
necessary for pDNA nuclear entry is not surprising, based on the
finding that all regulated transport studied to date requires proteins
found in the cytoplasm (1). Further, the ability of importin
,
importin
, and RAN to mediate the nuclear import of pDNA in the
presence of a nuclear extract that otherwise cannot support import
unifies the import of pDNA with that of other substrates, including
proteins and snRNPs. This requirement of the soluble NLS import
machinery or plasmid nuclear localization appears to be in contrast to
the results of Wolff and colleagues (13) who found that although
nuclear import of fluorescently labeled linear DNA fragments was
energy-dependent and inhibited by WGA, it occurred optimally in the absence of cytoplasmic proteins. The reason for this
disparity is unclear, but a possible explanation could reside in the
differences in substrates used for import. Uniformly labeled, short,
linear DNA and plasmid labeled at a discrete site are two very
different substrates and, as such, may utilize different pathways for
entry. Further, the choice of DNA sequence may have had an effect on
transport; whereas DNA fragments less than 1 kb may enter the nucleus
in the absence of cell extract and a DNA nuclear targeting sequence,
the inability of larger DNAs to enter could have been due to the lack
of such a sequence, and consequently, the lack of cytoplasmic extract.
Thus, with no DNA nuclear targeting sequence, transcription factors and
other DNA-binding proteins cannot bind to provide the DNA with the NLSs
needed for import by the importin pathway. Indeed, an absolute
requirement for cytoplasmic extract was observed by the same group when
NLS peptides were synthetically coupled to plasmid DNA (23).
The need for nuclear extract in addition to the importins and RAN for
plasmid DNA nuclear import supports our model for DNA nuclear
localization in which pDNA is targeted to the nucleus and translocated
by an importin pathway recognizing protein NLSs that are attached to
the DNA (4).2 That the SV40 DNA nuclear targeting sequence
contains binding sites for multiple transcription factors also supports
the model. Although we have not yet identified the protein(s) or
protein complex that binds to the DNA and provides the needed NLSs, it is clear that at least one or more of these proteins can interact with
importin
and importin
1 as opposed to other
homologues. However, it is also possible that additional transcription factors and
proteins bind to the DNA and aid in import by utilizing other importin
pathways as well (24). Several other examples in which NLS-containing
proteins are thought to mediate the nuclear localization of exogenous
DNA have been reported, including the matrix and Vpr proteins of HIV
for the cytoplasmic reverse transcribed HIV genome (25), the virD2 and
virE2 proteins of Agrobacterium tumefaciens for the
pathogenic T-DNA (26, 27), the Epstein-Barr virus EBNA-1 protein for
EBV oriP-containing plasmids (28), and the serum response factor for
plasmids containing the smooth muscle gamma actin promoter (29).
Further, many viral capsid and core proteins participate in the nuclear
localization of viral genomes, apparently by similar mechanisms
(30-33). Thus, such "piggy-back" transport of DNA appears a common
theme, both evolutionarily and experimentally.
Import of plasmid DNA can be thought to occur in three steps: formation
of the protein-DNA complex, transit to the NPC, and translocation. All
three of these processes probably require significant time to occur and
can account for the differences in time courses for plasmid nuclear
localization (hours) and that of individual proteins or snRNPs
(minutes) (4).2 The concentration of DNA-binding proteins
in the cytoplasm is expected to be low, limited mainly to those
proteins that have recently been translated and not yet targeted to the
nucleus. Although not rate-limiting in permeabilized cells because of
the excess of nuclear proteins added, the initial protein-DNA complex will form slowly in intact cells because it is a function of the concentration of the two substrates. Movement of this macromolecular complex through the cytoplasm is likely to encounter resistance because
of the presence of immobile objects and cytoskeletal elements, adding
to the time required for nuclear localization. Indeed, it has been
shown that cytoplasmic diffusion of dextrans with hydrodynamic radii
greater than 30 nm is greatly reduced compared with smaller species
(34, 35). Because size estimates for condensed plasmids range from 25 to 80 nm in diameter (36-38), their diffusion through the cytoplasm is
expected to be low. Finally, once at the NPC, the translocation event
itself should take much longer for DNA than for proteins, based on its
much larger size and shape and the fact that the rate of nuclear
transport is directly correlated to the molecular weight and shape of
the substrate (39, 40). It is unlikely that fully condensed plasmid is
imported into the nucleus without being partially hydrated, because the upper limit to the NPC transporter appears to be 28 nm (40), the same
as the lower limit for a condensed plasmid. Such similar unfolding or
hydration has been suggested to participate in the nuclear
translocation of similarly sized Balbiani Ring RNP particles (41).
It has recently been suggested that nuclear import of plasmid DNA may
begin by one NLS or a discrete foci of NLSs interacting with the NPC
machinery and being translocated and proceeds with the rest of the DNA
being pulled in because of the rapid formation of higher order
chromatin structures on the DNA as it enters into the nucleoplasm (42).
Alternatively, based on our finding that plasmid DNA nuclear entry is
dependent on transcription, it is also possible that the remainder of
the plasmid is pulled into the nucleus because of transcription of
plasmid DNA sequences (4). Thus, the presence of one NLS, or presumably
a discrete foci of NLSs, on a plasmid should be sufficient to initiate
the translocation process (42). It has also been proposed that the presence of one NLS on a plasmid will allow a plasmid to enter the
nucleus through an NPC much better than would multiple NLS distributed
around the plasmid (42). The reasoning is that multiple NLSs on one
plasmid could interact with multiple NPCs to arrest transport in a
"tug-of-war." Based on the average density of NPCs in the nuclear
envelope (43) and the persistence length of DNA, this would correspond
to interactions with an NPC once every kilobase (42). Although this is
an intriguing model, the demonstration that plasmids containing 70-100
NLSs distributed randomly around a plasmid are imported into the
nucleus suggests that this may not be universal (23). Furthermore, the
presence of DNA-binding domains facing the cytoplasm on several NPC
proteins would also have the same effect of arresting transport of
large DNAs, regardless of whether NLSs were present (44, 45). However,
with the ability to covalently attach NLS peptides to the amino termini
of PNAs and incorporate PNA target sequences at multiple sites around a
plasmid, this model is easily testable.
 |
ACKNOWLEDGEMENTS |
We thank Lou Smith (GeneMedicine, The
Woodlands, TX) for advice and the gift of the pGenegrip plasmids,
Karsten Weis (EMBL, Heidelberg, Germany) for the gift of pHSRP
, Mark
Goulian (Institute for Physics and Biology, The Rockefeller University,
New York, NY) for providing us with Fl-BSA-NLS, and Ray Hester for help using the confocal microscope. We also thank Felix Munkonge and Warren
Zimmer for helpful discussions and critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by Grant ALG 960006 from the
Alabama Affiliate of the American Heart Association (to D. A. D.), Grant 5-FY97-0692 from the March of Dimes Foundation (to G. W.), and Grants R01 HL59956 (to D. A. D.) and 5P60 HL38639 (to D. A. D. and G. W.) from the National Institutes of
Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
334-460-6406; Fax: 334-460-7931; E-mail:
Dean@sungcg.usouthal.edu.
2
D. A. Dean, B. S. Dean, S. Muller, and
L. C. Smith, submitted for publication.
3
Wang, G., Xu, X., Pace, B., Dean, D. A., Glazer,
P. M., Chan, P., Goodman, S. R., and Shoklenko, I. (1999) Nucleic
Acids Res. 27, 2806-2813.
 |
ABBREVIATIONS |
The abbreviations used are:
NPC, nuclear pore
complex;
NLS, nuclear localization signal;
HIV, human immunodeficiency
virus;
GFP, green fluorescent protein;
PNA, peptide nucleic acid;
Fl, fluorescein;
Rh, rhodamine;
BSA, bovine serum albumin;
BSA-NLS, synthetic NLS peptide-conjugated bovine serum albumin;
WGA, wheat germ
agglutinin;
pDNA, plasmid DNA;
bp, base pair(s);
kb, kilobase(s).
 |
REFERENCES |
| 1.
|
Mattaj, I. W.,
and Englmeier, L.
(1998)
Annu. Rev. Biochem.
67,
265-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Melchior, F.,
and Gerace, L.
(1998)
Trends Cell Biol.
8,
175-179
[CrossRef][Medline]
[Order article via Infotrieve] |
| 3.
|
Moroianu, J.
(1998)
J. Cell. Biochem.
70,
231-239[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Dean, D. A.
(1997)
Exp. Cell Res.
230,
293-302[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Weis, K.,
Mattaj, I. W.,
and Lamond, A. I.
(1995)
Science
268,
1049-1053[Abstract/Free Full Text]
|
| 6.
|
Moroianu, J.,
Blobel, G.,
and Radu, A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2008-2011[Abstract/Free Full Text]
|
| 7.
|
Adam, S. A.,
Marr, R. S.,
and Gerace, L.
(1990)
J. Cell Biol.
111,
807-816[Abstract/Free Full Text]
|
| 8.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1994)
Current Protocols in Molecular Biology
, John Wiley & Sons, New York
|
| 9.
|
Egholm, M.,
Buchardt, O.,
Christensen, L.,
Behrens, C.,
Freier, S. M.,
Driver, D. A.,
Berg, R. H.,
Kim, S. K.,
Norden, B.,
and Nielsen, P. E.
(1993)
Nature
365,
566-568[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Nielsen, P. E.,
Egholm, M.,
and Buchardt, O.
(1994)
Gene (Amst.)
149,
139-45[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Demidov, V. V.,
Potaman, V. N.,
Frank-Kamenetskii, M. D.,
Egholm, M.,
Buchardt, O.,
Sonnichsen, S. H.,
and Nielsen, P. E.
(1994)
Biochem. Pharmacol.
48,
1310-1313[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Marshallsay, C.,
and Lührmann, R.
(1994)
EMBO J.
13,
222-231[Medline]
[Order article via Infotrieve]
|
| 13.
|
Hagstrom, J. E.,
Ludtke, J. J.,
Bassik, M. C.,
Sebestyén, M. G.,
Adam, S. A.,
and Wolff, J. A.
(1997)
J. Cell Sci.
110,
2323-2331[Abstract]
|
| 14.
|
Holaska, J. M.,
and Paschal, B. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14739-44[Abstract/Free Full Text]
|
| 15.
|
Love, D. C.,
Sweitzer, T. D.,
and Hanover, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10608-10613[Abstract/Free Full Text]
|
| 16.
|
Moore, M. S.,
and Blobel, G.
(1992)
Cell
69,
939-950[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Zelphati, O.,
Liang, X.,
Hobart, P.,
and Felgner, P. L.
(1999)
Hum. Gene Ther.
10,
15-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Bentin, T.,
and Nielsen, P. E.
(1996)
Biochemistry
35,
8863-8869[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Graessman, M.,
Menne, J.,
Liebler, M.,
Graeber, I.,
and Graessman, A.
(1989)
Nucleic Acids Res.
17,
6603-6612[Abstract/Free Full Text]
|
| 20.
|
Escriou, V.,
Ciolina, C.,
Lacroix, F.,
Byk, G.,
Scherman, D.,
and Wils, P.
(1998)
Biochim. Biophys. Acta
1368,
276-288[Medline]
[Order article via Infotrieve]
|
| 21.
|
Beltinger, C.,
Saragovi, H. U.,
Smith, R. M.,
LeSauteur, L.,
Shah, N.,
DeDionisio, L.,
Christensen, L.,
Raible, A.,
Jarett, L.,
and Gewirtz, A. M.
(1995)
J. Clin. Invest.
95,
1814-1823
|
| 22.
|
Hartig, R.,
Shoeman, R. L.,
Janetzko, A.,
Grub, S.,
and Traub, P.
(1998)
Biol. Cell
90,
407-426[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Sebestyén, M. G.,
Ludtke, J. L.,
Bassik, M. C.,
Zhang, G.,
Budker, V.,
Lukhtanov, E. A.,
Hagstrom, J. E.,
and Wolff, J. A.
(1998)
Nat. Biotech.
16,
80-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Albertini, M.,
Pemberton, L. F.,
Rosenblum, J. S.,
and Blobel, G.
(1998)
J. Cell Biol.
143,
1447-1455[Abstract/Free Full Text]
|
| 25.
|
Stevenson, M.
(1996)
Trends Cell Biol.
6,
9-15
|
| 26.
|
Zupan, J. R.,
Citovsky, V.,
and Zambryski, P.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2392-2397[Abstract/Free Full Text]
|
| 27.
|
Shurvinton, C. E.,
Hodges, L.,
and Ream, W.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11837-11841[Abstract/Free Full Text]
|
| 28.
|
Langle-Rouault, F.,
Patzel, V.,
Benavente, A.,
Taillez, M.,
Silvestre, N.,
Bompard, A.,
Sczakiel, G.,
Jacobs, E.,
and Rittner, K.
(1998)
J. Virol.
72,
6181-6185[Abstract/Free Full Text]
|
| 29.
|
Vacik, J.,
Dean, B. S.,
Zimmer, W. E.,
and Dean, D. A.
(1999)
Gene Ther.
6,
1006-1014[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Whittaker, G. R.,
and Helenius, A.
(1998)
Virology
246,
1-23[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Nakanishi, A.,
Clever, J.,
Yamada, M.,
Li, P. L.,
and Kasamatsu, H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
96-100[Abstract/Free Full Text]
|
| 32.
|
Greber, U. F.,
and Kasamatsu, H.
(1996)
Trends Cell Biol.
6,
189-195
[CrossRef][Medline]
[Order article via Infotrieve] |
| 33.
|
Kann, M.,
Bischof, A.,
and Gerlich, W. H.
(1997)
J. Virol.
71,
1310-1316[Abstract]
|
| 34.
|
Luby-Phelps, K.,
Castle, P. E.,
Taylor, D. L.,
and Lanni, F.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4910-4913[Abstract/Free Full Text]
|
| 35.
|
Seksek, O.,
Biwersi, J.,
and Verkman, A. S.
(1997)
J. Cell Biol.
138,
131-142[Abstract/Free Full Text]
|
| 36.
|
Duguid, J. G.,
Li, C.,
Shi, M.,
Logan, M. J.,
Alila, H.,
Rolland, A.,
Tomlinson, E.,
Sparrow, J. T.,
and Smith, L. C.
(1998)
Biophys. J.
74,
2802-2814[Abstract/Free Full Text]
|
| 37.
|
Ma, C.,
and Bloomfield, V. A.
(1994)
Biophys. J.
67,
1678-1681[Abstract/Free Full Text]
|
| 38.
|
Blessing, T.,
Remy, J. S.,
and Behr, J. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1427-1431[Abstract/Free Full Text]
|
| 39.
|
Lanford, R. E.,
Kanda, P.,
and Kennedy, R. C.
(1986)
Cell
46,
575-582[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Dworetzky, S. I.,
Lanford, R. E.,
and Feldherr, C. M.
(1988)
J. Cell Biol.
107,
1279-1287[Abstract/Free Full Text]
|
| 41.
|
Mehlin, H.,
Daneholt, B.,
and Skoglund, U.
(1995)
J. Cell Biol.
129,
1205-1216[Abstract/Free Full Text]
|
| 42.
|
Zanta, M. A.,
Belguise-Valladier, P.,
and Behr, J. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
91-96[Abstract/Free Full Text]
|
| 43.
|
Maul, G. G.,
and Deaven, L.
(1977)
J. Cell Biol.
73,
748-760[Abstract/Free Full Text]
|
| 44.
|
Wu, J.,
Matunis, M. J.,
Kraemer, D.,
Blobel, G.,
and Coutavas, E.
(1995)
J. Biol. Chem.
270,
14209-14213[Abstract/Free Full Text]
|
| 45.
|
Sukegawa, J.,
and Blobel, G.
(1993)
Cell
72,
29-38[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit